Literature DB >> 29702060

Editorial Comment.

Steven Lehrer1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29702060      PMCID： PMC6746557          DOI： 10.1016/j.juro.2018.02.3112

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  5 in total

1.  Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.

Authors:  Shabbir M H Alibhai; Narhari Timilshina; Sarah Duff-Canning; Henriette Breunis; Ian F Tannock; Gary Naglie; Neil E Fleshner; Murray D Krahn; Padraig Warde; Shireen Marzouk; George A Tomlinson
Journal:  Cancer       Date:  2016-09-01       Impact factor: 6.860

2.  Risk of Alzheimer's Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer.

Authors:  Seo Hyon Baik; Fabricio Sampaio Peres Kury; Clement Joseph McDonald
Journal:  J Clin Oncol       Date:  2017-08-25       Impact factor: 44.544

3.  Androgen Deprivation Therapy and Future Alzheimer's Disease Risk.

Authors:  Kevin T Nead; Greg Gaskin; Cariad Chester; Samuel Swisher-McClure; Joel T Dudley; Nicholas J Leeper; Nigam H Shah
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

4.  OpenVigil FDA - Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications.

Authors:  Ruwen Böhm; Leocadie von Hehn; Thomas Herdegen; Hans-Joachim Klein; Oliver Bruhn; Holger Petri; Jan Höcker
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

5.  No Relationship of Anti-Androgens to Alzheimer's Disease or Cognitive Disorder in the MedWatch Database.

Authors:  Steven Lehrer; Peter H Rheinstein; Kenneth E Rosenzweig
Journal:  J Alzheimers Dis Rep       Date:  2018-06-30
  5 in total
  1 in total

1.  Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  Am J Clin Oncol       Date:  2020-10       Impact factor: 2.787
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.